Q515--New Five Year Blanket Purchase Agreement Salt Lake City Heart and Kidney Transplant Rejection Test Services and Reporting
Overview
Buyer
Place of Performance
NAICS
PSC
Set Aside
Original Source
Timeline
Qualification Details
Fit reasons
- NAICS alignment with historical contract wins in similar service areas.
- Scope strongly matches core technical capabilities and delivery model.
Risks
- Past performance thresholds may require one additional teaming partner.
- Potential clarification needed on staffing minimums before bid/no-bid.
Next steps
Validate eligibility requirements, assign capture owner, and schedule partner outreach to confirm teaming strategy before submission planning.
Quick Summary
The Department of Veterans Affairs (VA), Network Contract Office 19, is seeking proposals for a new Five-Year Blanket Purchase Agreement (BPA) for Heart and Kidney Transplant Rejection Test Services and Reporting for the Salt Lake City VA Medical Center. This unrestricted opportunity requires specialized molecular testing using the Molecular Microscope Diagnostic System (MMDx). Quotes are due by January 30, 2026, at 15:00 MT.
Scope of Work
The contractor will provide post-transplant Molecular Microscope Diagnostic System (MMDx) Expression testing, performing specialized genetic testing on biopsy samples from veteran transplant patients to determine organ rejection or injury. This includes laboratory testing, analysis, result interpretation, and consultative services. All testing must be performed entirely on the contractor's premises. The BPA covers an estimated annual volume of 20 tests for both heart and kidney, totaling 100 of each over the five-year period.
Contract Details
- Contract Type: Firm-Fixed Price Blanket Purchase Agreement (BPA)
- Period of Performance: Five one-year ordering periods, from March 1, 2026, to February 28, 2031.
- Place of Performance: Contractor's premises (for testing); services support the Salt Lake City VA Medical Center.
- Set-Aside: Unrestricted
- NAICS Code: 621511 (Medical Laboratories) with a $41.5 Million size standard.
- Pricing: Per test, with heart and kidney assays priced separately. Shipping kits and consultative services must be included in the pricing. Price escalations are permitted across ordering periods, with firm-fixed pricing for each period.
Key Requirements & Compliance
The Molecular Microscope Diagnostic System (MMDx) is specifically required, though CLIA-validated laboratory-developed tests are acceptable. Turnaround times are critical: 48-72 hours for heart transplant testing and 24-48 hours for kidney transplant testing, both defined from specimen receipt, with the clock pausing on weekends and federal holidays. Results must be provided as categorical risk levels. The contractor must be a single CLIA-certified laboratory; international laboratories are prohibited. Full licensure and accreditation (CAP, CLIA) are mandatory prior to award, along with HIPAA compliance and robust quality assurance programs. Access to a Medical Science Liaison for reviewing results during business hours is expected.
Submission & Evaluation
- Quote Submission Deadline: January 30, 2026, at 15:00 Mountain Time.
- Submission Method: Email quotes to Lindsey.Zwaagstra@va.gov.
- Evaluation Factors: Award will be made on an "All or Nothing" basis following a Comparative Analysis, considering Technical Capability/Quality, Price, and Past Performance. Past performance will be weighted against price.